A blueprint for academic laboratories to produce SARS-CoV-2 quantitative RT-PCR test kits
- PMID: 32883809
- PMCID: PMC7667971
- DOI: 10.1074/jbc.RA120.015434
A blueprint for academic laboratories to produce SARS-CoV-2 quantitative RT-PCR test kits
Abstract
Widespread testing for the presence of the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals remains vital for controlling the COVID-19 pandemic prior to the advent of an effective treatment. Challenges in testing can be traced to an initial shortage of supplies, expertise, and/or instrumentation necessary to detect the virus by quantitative RT-PCR (RT-qPCR), the most robust, sensitive, and specific assay currently available. Here we show that academic biochemistry and molecular biology laboratories equipped with appropriate expertise and infrastructure can replicate commercially available SARS-CoV-2 RT-qPCR test kits and backfill pipeline shortages. The Georgia Tech COVID-19 Test Kit Support Group, composed of faculty, staff, and trainees across the biotechnology quad at Georgia Institute of Technology, synthesized multiplexed primers and probes and formulated a master mix composed of enzymes and proteins produced in-house. Our in-house kit compares favorably with a commercial product used for diagnostic testing. We also developed an environmental testing protocol to readily monitor surfaces for the presence of SARS-CoV-2. Our blueprint should be readily reproducible by research teams at other institutions, and our protocols may be modified and adapted to enable SARS-CoV-2 detection in more resource-limited settings.
Keywords: DNA polymerase; RNA; RT-qPCR; SARS-CoV-2; coronavirus; formulation; infectious disease; polymerase chain reaction (PCR); protein purification; reverse transcriptase; reverse transcription; ribonuclease inhibitor; virus.
© 2020 Mascuch et al.
Conflict of interest statement
Conflict of interest—The authors declare that they have no conflicts of interest with the contents of this article.
Figures
Update of
-
A blueprint for academic labs to produce SARS-CoV-2 RT-qPCR test kits.medRxiv [Preprint]. 2020 Sep 1:2020.07.29.20163949. doi: 10.1101/2020.07.29.20163949. medRxiv. 2020. Update in: J Biol Chem. 2020 Nov 13;295(46):15438-15453. doi: 10.1074/jbc.RA120.015434. PMID: 32766604 Free PMC article. Updated. Preprint.
References
-
- Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W., Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y., Wang Q.-M., et al. (2020) A new coronavirus associated with human respiratory disease in China. Nature 579, 265–269 10.1038/s41586-020-2008-3 - DOI - PMC - PubMed
-
- Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., Si H.-R., Zhu Y., Li B., Huang C.-L., Chen H.-D., Chen J., Luo Y., Guo H., Jiang R.-D., et al. (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 10.1038/s41586-020-2012-7 - DOI - PMC - PubMed
-
- Patel R., Babady E., Theel E. S., Storch G. A., Pinsky B. A., George K. S., Smith T. C., and Bertuzzi S. (2020) Report from the American Society for Microbiology COVID-19 international summit, 23 March 2020: value of diagnostic testing for SARS–CoV-2/COVID-19. mBio 11, e00722–20 10.1128/mBio.00722-20 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
